Analystreport

Adaptive Biotechnologies Co. (NASDAQ: ADPT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $43.00 pr

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com